NL8103804A - Basische analgetische capsule. - Google Patents

Basische analgetische capsule. Download PDF

Info

Publication number
NL8103804A
NL8103804A NL8103804A NL8103804A NL8103804A NL 8103804 A NL8103804 A NL 8103804A NL 8103804 A NL8103804 A NL 8103804A NL 8103804 A NL8103804 A NL 8103804A NL 8103804 A NL8103804 A NL 8103804A
Authority
NL
Netherlands
Prior art keywords
capsule
aspirin
unit dosage
dosage form
basic
Prior art date
Application number
NL8103804A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/179,191 external-priority patent/US4294819A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8103804A publication Critical patent/NL8103804A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8103804A 1980-08-18 1981-08-13 Basische analgetische capsule. NL8103804A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17919180 1980-08-18
US06/179,191 US4294819A (en) 1980-08-18 1980-08-18 Alkaline analgesic capsule
US06/273,015 US4339428A (en) 1980-08-18 1981-06-18 Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US27301581 1981-06-18

Publications (1)

Publication Number Publication Date
NL8103804A true NL8103804A (nl) 1982-03-16

Family

ID=26875096

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103804A NL8103804A (nl) 1980-08-18 1981-08-13 Basische analgetische capsule.

Country Status (25)

Country Link
US (1) US4339428A (es)
AT (1) AT370624B (es)
AU (1) AU549488B2 (es)
CA (1) CA1156554A (es)
CH (1) CH646331A5 (es)
DD (1) DD201643A5 (es)
DE (1) DE3132518A1 (es)
DK (1) DK159374C (es)
ES (1) ES504797A0 (es)
FI (1) FI77371C (es)
FR (1) FR2488508A1 (es)
GB (1) GB2082456B (es)
GR (1) GR74618B (es)
HU (1) HU187354B (es)
IE (1) IE51501B1 (es)
IL (1) IL63577A0 (es)
IT (1) IT1143221B (es)
LU (1) LU83559A1 (es)
NL (1) NL8103804A (es)
NO (1) NO155476C (es)
NZ (1) NZ198045A (es)
OA (1) OA06883A (es)
PT (1) PT73530B (es)
SE (1) SE451667B (es)
ZW (1) ZW19781A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
EP0320550A1 (en) * 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
AU643703B2 (en) * 1989-09-15 1993-11-25 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
US5391230A (en) * 1993-07-07 1995-02-21 Eastman Kodak Company Apparatus for holding solid compact medicaments during processing
EP0778770B1 (en) * 1994-09-02 2003-12-10 Virginia Commonwealth University Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6511494B1 (en) 2000-11-17 2003-01-28 Embro Corporation Vein harvesting system and method
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
EP1642593A1 (en) * 2003-06-06 2006-04-05 Takeda Pharmaceutical Company Limited Solid pharmaceutical preparation
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20060222705A1 (en) * 2005-03-31 2006-10-05 Flanner Henry H Pharmaceutical tablet and apparatus and method for making
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
DE102008025798C5 (de) 2008-05-29 2015-08-06 Guangdong Fushan Glass Machinery Co., Ltd. Verfahren zum Betreiben eines Rollenofens
WO2011008546A2 (en) * 2009-06-29 2011-01-20 Capricorn Pharma, Inc. Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof
CA2784041C (en) 2010-01-05 2017-11-07 Microdose Therapeutx, Inc. Inhalation device and method
US20130143867A1 (en) * 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
EP3359131A4 (en) * 2015-10-09 2019-05-01 Combocap, Inc. CAPSULE WITH INTERNAL MEMBRANES FOR IMPROVED BIOVERABILITY

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA593581A (en) * 1960-03-01 W. E. Harrisson Joseph Analgesic product
FR808949A (fr) * 1936-07-31 1937-02-18 Perfectionnements à la préparation des cachets pharmaceutiques
US2224256A (en) * 1938-08-05 1940-12-10 Baker Chem Co J T Pharmaceutical preparation
GB613080A (en) * 1946-05-17 1948-11-22 Myer Coplans Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
US2698332A (en) * 1951-04-20 1954-12-28 Reheis Company Inc Aspirin derivative and method of making
GB754364A (en) * 1953-10-09 1956-08-08 Drug Houses Of Australia Ltd Improvements in medicinal preparations containing acetylsalicylic acid
US2918485A (en) * 1955-09-21 1959-12-22 Keystone Chemurgic Corp Dihydroxy aluminum salicylates
US2889248A (en) * 1955-12-13 1959-06-02 Drug Processors Inc Therapeutic composition containing aluminum proteinate
US2801951A (en) * 1956-01-09 1957-08-06 Sterling Drug Inc Stabilized analgesic compositions
GB827529A (en) * 1956-02-27 1960-02-03 Macleans Ltd Improvements in or relating to the manufacture of tablets
US2888382A (en) * 1957-10-28 1959-05-26 Upjohn Co Therapeutic composition and process
NL245245A (es) * 1958-04-18
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3323992A (en) * 1960-09-29 1967-06-06 Keystone Chemurgic Corp Antacid composition of hydrated magnesium aluminate containing bound sulfate
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
GB1204580A (en) 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3608064A (en) * 1969-10-07 1971-09-21 Anthony H Lamb Milk-buffered aspirin
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule

Also Published As

Publication number Publication date
AT370624B (de) 1983-04-25
CH646331A5 (de) 1984-11-30
FR2488508A1 (fr) 1982-02-19
NO812678L (no) 1982-02-19
NO155476B (no) 1986-12-29
GB2082456B (en) 1984-10-24
DK362781A (da) 1982-02-19
IE51501B1 (en) 1987-01-07
ATA355281A (de) 1982-09-15
SE451667B (sv) 1987-10-26
DE3132518A1 (de) 1982-05-27
GB2082456A (en) 1982-03-10
NO155476C (no) 1987-04-08
GR74618B (es) 1984-06-29
FI77371C (fi) 1989-03-10
SE8104881L (sv) 1982-02-19
CA1156554A (en) 1983-11-08
AU7368281A (en) 1982-02-25
AU549488B2 (en) 1986-01-30
NZ198045A (en) 1985-01-31
US4339428A (en) 1982-07-13
HU187354B (en) 1985-12-28
IL63577A0 (en) 1981-11-30
DK159374B (da) 1990-10-08
PT73530B (en) 1983-10-20
ES8301622A1 (es) 1982-12-16
FI812505L (fi) 1982-02-19
ZW19781A1 (en) 1982-06-16
PT73530A (en) 1981-09-01
IE811881L (en) 1982-02-18
IT8149078A0 (it) 1981-08-10
OA06883A (fr) 1983-04-30
ES504797A0 (es) 1982-12-16
DD201643A5 (de) 1983-08-03
FI77371B (fi) 1988-11-30
DK159374C (da) 1991-07-01
FR2488508B1 (es) 1985-05-10
IT1143221B (it) 1986-10-22
LU83559A1 (fr) 1982-04-14

Similar Documents

Publication Publication Date Title
NL8103804A (nl) Basische analgetische capsule.
US4664915A (en) Compressed and formed alkaline component suitable for use in buffered aspirin product
US4294819A (en) Alkaline analgesic capsule
AU752214B2 (en) Flash-melt oral dose formulations
KR100238550B1 (ko) 작용개시의 향상 및 효력의 증가를 위한 연하정
ES2745438T3 (es) Formulación robusta de comprimidos de desintegración rápida
RU2089193C1 (ru) Фармацевтическая композиция для орального применения на основе дезоксипуринового нуклеозида, обладающая антивирусной активностью
TW508242B (en) Pharmaceutical composition comprising paracetamol
US10258562B2 (en) Effervescent tablet containing high level of aspirin
KR880001933B1 (ko) 완충-아스피린의 생성에 적합한 압착 형성된 알카리성 조성물 및 그것의 제조방법
EP0599767B1 (en) Process to prepare water-dispersable tablets containing diclofenac
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
Guggilla Fast dissolving tablets
JP4658306B2 (ja) 錠剤用医薬組成物
WO2023281449A1 (en) Method of production of the composition of cyclooxygenase-2 (cox-2) inhibitors
MXPA00006125A (es) Formulacion de dosificacion oral de fusion instantanea

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BV The patent application has lapsed